Revenue
2019
2020
2021
2022
2023
2024
2025
2026
PharmaCyte Biotech, Inc. (PMCB)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2013
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12,160 | $66,558 | $125,997 |
| Gross profit | — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $2,540 | $47,175 | $93,893 |
| Research & development | $391,301 | $438,416 | $407,431 | $468,536 | $690,937 | $916,249 | $301,221 | $460,052 | $2.0M | $1.2M | $1.4M | $3.5M | $323,500 | $0 | — | — |
| Operating expenses | $6.9M | $4.4M | $8.5M | $6.5M | $4.4M | $3.6M | $3.8M | $4.1M | $7.0M | $4.4M | $6.1M | $13.3M | $19.0M | $1.7M | $2.0M | $482,254 |
| Operating income | −$6.9M | −$4.4M | −$8.5M | −$6.5M | −$4.4M | −$3.6M | −$3.8M | −$4.1M | −$7.0M | −$4.4M | −$6.1M | −$13.3M | −$19.0M | −$1.7M | −$1.9M | — |
| EBITDAderived | — | — | — | — | — | — | — | — | — | — | — | — | — | −$1.7M | −$1.9M | — |
| Net income | −$19.4M | $30.7M | $333,763 | −$4.3M | −$4.2M | −$3.6M | −$3.8M | −$4.1M | −$6.8M | −$4.4M | −$6.1M | −$9.9M | −$27.3M | −$1.6M | −$1.9M | −$1.4M |
| Basic EPSper diluted share | -$2.77 | $3.19 | -$1.80 | -$0.22 | -$0.27 | -$2.45 | -$4.23 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.05 | $0.00 | -$0.01 | $0.00 |
| Diluted EPSper diluted share | -$2.77 | $3.19 | -$1.80 | -$0.22 | -$0.27 | -$2.45 | -$4.23 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.05 | $0.00 | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 7, 2026Form 4 | Silverman JoshuaCEO and President | BuyCommon Stock | 40.0K | $0.83 | $33.2K | 416.3K |
| Jan 7, 2026Form 4 | SCHECHTER JONATHANDirector | BuyCommon Stock | 20.0K | $0.84 | $16.8K | 192.5K |
| Jan 6, 2026Form 4 | Silverman JoshuaCEO and President | BuyCommon Stock | 30.0K | $0.79 | $23.7K | 376.3K |
| Jan 6, 2026Form 4 | SCHECHTER JONATHANDirector | BuyCommon Stock | 20.0K | $0.79 | $15.8K | 172.5K |
| Jan 5, 2026Form 4 | Silverman JoshuaCEO and President | BuyCommon Stock | 30.0K | $0.78 | $23.4K | 346.3K |